A clinical-stage biotechnology company focused on developing oral immunotherapies targeting gastrointestinal diseases and immune-related conditions. Its lead programs are derived from bovine colostrum antibodies designed to prevent or treat infectious and inflammatory gut disorders, including travel...
1 member of Congress has disclosed 1 trade in Imrion Technologies Inc Class A (IMRN), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-19 | Rohit Khanna | buy | $1K – $15K |